Status:
COMPLETED
Economic Outcomes of Enteral and Parenteral Proton Pump Inhibitor (PPI) Use in the Intensive Care Unit (ICU)
Lead Sponsor:
University of Nebraska
Collaborating Sponsors:
Takeda
Conditions:
Stress Ulcer Prophylaxis
Eligibility:
All Genders
19+ years
Brief Summary
This study will be a retrospective electronic medical chart review of all patients admitted to adult intensive care medicine units (ICU) at The Nebraska Medical Center over a three-year period from Ja...
Detailed Description
BACKGROUND AND SIGNIFICANCE: Detail: Proton pump inhibitors (PPIs) are commonly used in intensive care unit (ICU) patients for various clinical conditions, including acute stress related gastrointest...
Eligibility Criteria
Inclusion
- All patients greater than 18 years admitted to the ICU during 2006-2008 (January 2006 through December 2008; 3-year period)
Exclusion
- Patients ineligible to receive a PPI (e.g. hypersensitivity to any PPI)
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
534 Patients enrolled
Trial Details
Trial ID
NCT00919152
Start Date
July 1 2009
End Date
January 1 2012
Last Update
October 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unversity of Nebraska Medical Center
Omaha, Nebraska, United States, 68198